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A grand challenge in synthetic biology is to push the design of biomolecular
circuits from purely genetic constructs towards systems that interface different
levels of the cellular machinery, including signalling networks and metabolic
pathways. In this paper, we focus on a genetic circuit for feedback regulation
of unbranched metabolic pathways. The objective of this feedback system is
to dampen the effect of flux perturbations caused by changes in cellular
demands or by engineered pathways consuming metabolic intermediates. We
consider a mathematical model for a control circuit with an operon architecture,
whereby the expression of all pathway enzymes is transcriptionally repressed
by the metabolic product. We address the existence and stability of the
steady state, the dynamic response of the network under perturbations, and
their dependence on common tuneable knobs such as the promoter character-
istic and ribosome binding site (RBS) strengths. Our analysis reveals trade-offs
between the steady state of the enzymes and the intermediates, together with a
separation principle between promoter and RBS design. We show that enzy-
matic saturation imposes limits on the parameter design space, which must
be satisfied to prevent metabolite accumulation and guarantee the stability of
the network. The use of promoters with a broad dynamic range and a small
leaky expression enlarges the design space. Simulation results with realistic
parameter values also suggest that the control circuit can effectively
upregulate enzyme production to compensate flux perturbations.1. Introduction
Synthetic biology aims at engineering cellular systems to perform customized
and programmable biological functions. The seminal works published in
2000 [1,2] kick-started the development of a wide range of gene circuits with
prescribed functions, including bacterial logic gates [3], mechanisms for pro-
grammed cell-to-cell communication [4] and light-responsive modules [5].
This progress has recently been followed by the so-called ‘second wave’ of
synthetic biology [6], which aims at scaling up the designs from individual gen-
etic modules to whole cellular systems that operate across different layers of
cellular regulation, including signalling networks and metabolic pathways [7,8].
One of the most prominent applications of synthetic biology is the manipu-
lation of bacterial metabolism for chemical production in sectors such as
energy, biomedicine and food technology [6]. Effective control of metabolism
hinges on the ability to upregulate or downregulate pathways in response to
changes in the intracellular conditions, cell requirements or environmental per-
turbations [9]. These requirements call for dynamic control strategies that
can modulate enzyme expression in a metabolite-dependent fashion [10,11].
One of the key bottlenecks in this respect is our limited understanding of
how genetic design knobs modulate the metabolic responses.
The goal of this paper is to reveal new insights into the design limitations and
trade-offs arising from the interplay between gene circuits andmetabolic pathways.
To that end, we analyse a dynamic model for a feedback system comprising non-
linear kinetic equations for the metabolic species, together with product-
dependent enzyme expression controlled by a synthetic gene circuit. We focus
substrate
(a) (b)
metabolic
pathway
genetic controller
metabolite
catalytic enzymes
substrate
pool
cellular
processes
engineered
pathways
effectorenzymeexpression
Figure 1. Control design for metabolic pathways. (a) Transcriptional regulation of metabolic pathways seen as a feedback control system: effector molecules (such as
transcription factors) sense metabolite concentrations and modulate the expression of catalytic enzymes, which act as inputs to the pathway. (b) Engineered
pathways can divert part of the native metabolic flux to the production of foreign compounds. (Online version in colour.)
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2on the existence and stability of the steady state, the dynamic
response of the network under perturbations and the depen-
dence of these on the design knobs of the synthetic gene circuit.
Two landmark implementations of engineered genetic–
metabolic circuits are the genetic control of lycopene
production [12] and the metabolic oscillator described in
Fung et al. [13]. These works were followed up by the recent
study by Zhang et al. [14], whereby the authors reported the
first successful implementation of a genetic control circuit to
increase biofuel production. In a way akin to man-made tech-
nological systems, the use of feedback control plays a pivotal
role in ‘robustifying’ pathway dynamics under changing
environmental conditions, cell-to-cell variability and bio-
chemical noise. Despite the ubiquity of control engineering
methods [15], only a few works have rigorously addressed
the problem of genetic feedback design on the basis of math-
ematical models. Notably, Anesiadis et al. [16] demonstrated
the use of a genetic toggle switch [2] as an ON–OFF controller
for metabolism, whereas Dunlop et al. [17] explored different
genetic control architectures for biofuel production.
From a control engineering standpoint, catalytic enzymes
act as inputs to ametabolic pathway in order to drive themetab-
olite dynamics (i.e. the outputs). The pathway outputs are then
sensed by metabolite-responsive molecules that can modulate
enzyme expression levels (e.g. transcription factors (TFs) or
riboswitches [18]). In the control engineering jargon, this feed-
back system can be seen as a ‘plant’ (i.e. the pathway to be
controlled), and a ‘controller’ (i.e. the gene regulatory circuit
controlling the expression of the catalytic enzymes); see
figure 1a. The design of the genetic controllermust then account
for two complementary control objectives: firstly, it must dyna-
mically adjust pathway activity to match the cellular demand
for product and sustain the homeostatic balance of native cellu-
lar processes. Secondly, a common strategy in metabolic
engineering is to modify host microbes by expressing heter-
ologous enzymes that convert metabolic intermediates into a
chemical of interest [19]. The consumption of intermediates
diverts part of the flux allocated to the host native processes
(figure 1b), and, therefore, the controller must also alleviate
the impact of these engineered pathways on the native flux.
In this paper, we study an unbranched metabolic path-
way under transcriptional repression from the product. The
synthetic circuit consists of an operon encoding all the cataly-
tic enzymes that is repressed by a product-responsive TF (§2).
The operon feedback architecture mimics natural circuits
enabling cellular adaptations to environmental perturbations
(e.g. in bacterial amino acid metabolism [20] and nutrient
uptake [21]). To maintain a general analysis, we do not
specify the kinetics of the metabolic model, but rather work
with a generic class of enzyme turnover rates satisfyingmild assumptions. These are satisfied by a wide range of
saturable enzyme kinetics, including Michaelis–Menten kin-
etics and cooperative behaviour described by sigmoidal
kinetics [22]. We parameterize the genetic model in terms
of the promoter characteristic and the ribosome binding site
(RBS) strengths, which are typical design elements used as
tuneable knobs in synthetic biology applications. As with
the enzyme kinetics, we do not fix the shape of the promoter
characteristic, but rather consider a generic class of repressive
functions that account, in particular, for the standard Hill
equation model for transcriptional repression [23].
Model analysis revealed that enzymatic saturation and
promoter leaky expression limit the RBS strength design
space (§3.1). These constraints must be satisfied to guarantee
the existence of an equilibrium point, to prevent the accumu-
lation of metabolites and to ensure the stability of the
network under small perturbations. The feasible set for the
RBS strengths depends critically on the promoter leakiness
and substrate availability. Within the feasible set, RBS
strengths may be used to fine-tune the balance between the
intermediate metabolite levels and the gene expression
burden imposed on the host cell. We also obtained analytical
formulae for the modes of the feedback system; these showed
that the operon architecture leads to slow fixed modes, and
suggests a separation principle between the effect of RBS
strengths and the promoter characteristic (§3.2).
We also show that engineered pathways consuming an inter-
mediate add further constraints to the RBS strengths design
space, which can be relaxed by using promoters with a high
dynamic range and small leakiness (§4.1). We performed
numerical simulations of themodelwith physiologically realistic
parameters in Escherichia coli (§§3.2 and 4.2). The simulations
show that the control circuit can effectively upregulate enzyme
production to compensate an increase in the cell’s native
demand for product and the impact of engineered pathways.
These also suggest that, in termsof both flux andproducthomeo-
stasis, the synthetic circuit always outperforms an uncontrolled
pathway (i.e. with constant enzyme levels), thus highlighting
the advantages of using a dynamic feedback control strategy.2. Unbranched pathway under transcriptional
feedback regulation
We consider an unbranched metabolic pathway as in figure 2b,
where s0 denotes the concentration of substrate, s1 and s2 are
intermediate metabolites and s3 is the metabolic product. The
metabolic reactions occur at a rate vi (each one catalysed by an
enzymewith concentration ei) and d denotes the rate of product
consumption by the cell. The metabolic genes are encoded in a
ribosome
binding site
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Figure 2. Generic model for an unbranched metabolic pathway under
transcriptional repression from the product. The enzymes ei catalyse the
reactions at a rate vi, and the cell consumes the product at a rate d. The
enzymes are encoded in an operon under the control of a single promoter
that is repressed by a TF. (Online version in colour.)
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3single operon controlled by a product-responsive TF that
represses enzyme expression. This kind of transcriptional feed-
back is common, for example, in bacterial nutrient uptake
systems (e.g. the lactose operon [21]) and amino acid
metabolism (e.g. the tryptophan operon [20]). 201206712.1. Metabolic pathway
The network in figure 2 exchanges mass with the environ-
ment and/or other networks in the cell. The model
accounts for this interaction via the input substrate s0 and
the product consumption rate d. We are interested in biologi-
cally meaningful phenotypes, and, therefore, we assume that
s0 is constant to ensure that, the network can reach a non-zero
steady state [24]. Note that, if the substrate decays in time, the
network eventually reaches a zero equilibrium, whereby the
substrate, intermediate metabolites and product are fully
depleted. The constant substrate assumption is also suitable
for scenarios where s0 is an extracellular substrate pool
shared by a low-density cell population (so that the effects
of cell-to-cell competition are negligible).
In a pathway with n reactions and n metabolites, the rate
of change of metabolite concentrations can be described by
_si ¼ viðsi1; eiÞ  viþ1ðsi; eiþ1Þ; ð2:1Þ
for i ¼ 1, 2, . . . , n and vnþ1 ¼ d(sn). This model arises from the
mass balance between the reactions that produce and con-
sume si, and the enzyme kinetics are included in the
reaction rates vi(si21, ei). To keep a general analysis, we will
not presuppose a specific form for the enzyme kinetics.
Instead, we will generically assume that the metabolic
reaction rates are linear in the enzyme concentrations [22]
viðsi1; eiÞ ¼ giðsi1Þei; ð2:2Þ
where giðÞ is the enzyme turnover rate (i.e. the reaction rate per
unit of enzyme concentration) satisfying gi(0)¼ 0. We will also
assume that the enzyme turnover rates are increasing and
saturable functions of the metabolite concentrations, so that
g0iðsi1Þ ¼
@giðsi1Þ
@si1
. 0 ð2:3Þ
and
lim
si1!1
giðsi1Þ ¼ g^i : ð2:4Þ
Assumptions (2.2)–(2.4) account for a broad class of saturable
enzyme kinetics, including both irreversible Michaelis–
Menten and Hill equation kinetics [22,25].
The rate of product consumption d(sn) is typically mod-
elled as a saturable function of Michaelis–Menten type [20],
but, for the sake of generality, we will consider a generic satur-
able function d(sn) satisfying d(0) ¼ 0, d0 ¼ @dðsnÞ=@sn . 0 andlimsn!1dðsnÞ ¼ dmax (cf. assumptions (2.3) and (2.4) for the
turnover rates). The cellular demand for product depends on
the concentration of a product-catalysing enzyme (which is
not explicitly modelled in (2.1)). For typical consumption
kinetics such as the Michaelis–Menten or Hill equation, the
maximal consumption rate dmax is proportional to the enzyme
concentration, and therefore in our model we can describe
changes in cellular demand as changes in the parameter dmax.2.2. Synthetic gene circuit
In an operon architecture all the enzymes are under the con-
trol of a single promoter (for the multi-promoter case see
[26]), and therefore we model the expression of catalytic
enzymes as
_ei ¼ bi|{z}
RBS
strength
ðk0 þ k1sðsnÞÞ|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
promoter
characteristic
giei; ð2:5Þ
for i¼ 1, 2, . . ., n. This model comes from the balance between
protein synthesis and degradation. We consider a first-order
degradation process with kinetic constants gi, which accounts
for the aggregate effect of degradation and dilution by cell
growth. A common strategy in synthetic biology is to control
protein degradation by adding a degradation tag to the
gene sequence [27], and thus we assume that all enzymes are
tagged and degraded at the same rate, i.e. gi¼ g. In the model
(2.5), we have parameterized enzyme expression in terms
of the promoter characteristic and RBS strengths, both of
which are common design elements in synthetic gene circuits
(figure 3a):
— Promoter characteristic. It describes the regulatory effect
of the TF on gene transcription. The function sðÞ depends
on the specific molecular mechanisms underlying the
product–TF and TF–promoter interactions. In order to
keep a generic description of the regulatory effect, and
to parameterize the model in terms of experimentally
accessible design parameters, we opt for a phenomenolo-
gical description of the promoter characteristic. We
therefore consider a function sðÞ that depends directly
on the product concentration and represents the net
effect of the product on the transcription rates. Gene tran-
scription under the action of a repressible promoter is
typically modelled using Hill functions, but to keep the
analysis general we consider generic transcription repres-
sion functions satisfying s(0) ¼ 1, s0 ¼ @s=@sn , 0 and
limsn!1sðsnÞ ¼ 0.
Promoters are typically described in terms of their
tightness (k0) and strength (k1); see figure 3b. The tightness
refers to the level of baseline transcription (i.e. under full
repression by the product), whereas the strength is the
gap between the ON and OFF transcription levels. The
promoter strength is quantified in terms of the dynamic
range m,
m ¼ k
0 þ k1
k0
: ð2:6Þ
Note that, since the promoter strength is always positive,
the dynamic range satisfies m  1, and we can model the
uncontrolled case (i.e. pure constitutive expression with-
out regulation) by taking m ¼ 1.
— Ribosome binding site strengths. RBSs are mRNA sequences
that are bound by the ribosomes to initiate translation
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Figure 3. Tuneable knobs in a synthetic operon control circuit. (a) The promoter characteristic and RBS strengths modulate gene transcription and translation rates,
respectively (the symbols are described in the legend of figure 2). (b) Sigmoidal characteristic of a repressible promoter. (Online version in colour.)
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4[10]. The translation rate of the enzymes can then be
modified by choosing RBS sequences with different affi-
nities to ribosome binding [28]. We model the effect of
the RBS strengths on the enzyme expression rate via the
parameters bi.
With the above assumptions and definitions, we can
write the complete model for the feedback system as
_si ¼ giðsi1Þei  giþ1ðsiÞeiþ1; i ¼ 1; 2; . . . ; n 1;
_sn ¼ gnðsn1Þen  dðsnÞ;
_ei ¼ biðk0 þ k1sðsnÞÞ  gei; i ¼ 1; 2; . . . ;n:
9=
;
ð2:7Þ
In the remainder of the paper, we focus on the existence
and stability of the steady state of the model (2.7), its
response to perturbations, and its behaviour as a function
of the promoter characteristic and the RBS strengths.
3. Circuit design for cellular demands
3.1. Trade-offs and constraints in the design of
ribosome binding site strengths
The operon circuit must be able to sustain a metabolic flux
that feeds the product into the downstream native processes
of the host. In this section, we show how this essential
requirement translates into constraints on the RBS strength
design space.
We will denote the steady-state metabolite concentrations,
enzyme concentrations and reaction rates as si, ei and vi,
respectively. We first note that the steady-state enzyme concen-
trations can be obtained by setting _ei ¼ 0 in (2.7), leading to
ei ¼ bi
g
ðk0 þ k1sðsnÞÞ; for all i: ð3:1Þ
At steady state, the product consumption rate dðsnÞ determines
the metabolic flux of the network by the relation v1 ¼ dðsnÞ,
and therefore the steady-state product concentration must
satisfy dðsnÞ ¼ g1ðs0Þe1. Combining this expression with (3.1)
for the first enzyme, we obtain an implicit equation for the
steady-state concentration of the product
dðsnÞ
g1ðs0Þ ¼
b1
g
ðk0 þ k1sðsnÞÞ: ð3:2ÞThe equilibrium concentrations of the intermediates can
be obtained by setting giðsi1Þei ¼ g1ðs0Þe1 for i  2,
giðsi1Þ ¼ g1ðs0Þ
e1
ei
¼ g1ðs0Þ bib1
 1
; for all i  2: ð3:3Þ
The solution of the implicit equation (3.3) gives the steady-
state concentrations of the intermediates as a function of the
RBS ratio bi/b1. Note that because the enzyme turnover
rates gi are monotonically increasing functions, increasing
the bi/b1 ratio leads to a lower steady-state concentration of
the intermediate si21. From equations (3.2) and (3.3), we
can infer how the different tuning knobs affect the steady
state of the network:
— Effect of the promoter characteristic. From the steady-state
equation in (3.2), we can calculate (see appendix A.1 for
a detailed derivation) the sensitivity of the product con-
centration to changes in promoter tightness k0, promoter
strength k1 or RBS strength b1,
dsn
dk0
¼ b1
g
FðsnÞ; ð3:4Þ
dsn
dk1
¼ b1
g
sðsnÞFðsnÞ ð3:5Þ
and
dsn
db1
¼ dðsnÞ
g1ðs0Þb1 Fð
snÞ; ð3:6Þ
where FðsnÞ ¼ ðd0ðsnÞ=g1ðs0Þ  ðb1k1=gÞs0ðsnÞÞ1. We note
that since d0ðsnÞ . 0 and s0ðsnÞ , 0, the function FðÞ is
positive and therefore the sensitivities in (3.4)–(3.6) are
also positive. We thus conclude that an increase in the
promoter parameters (k0 and k1) or RBS strength b1 will
lead to a higher steady-state product concentration,
which in turn translates into a higher flux. Moreover,
since the genes cannot be transcribed at a rate beyond
(k0þ k1), from (3.2), we observe that the flux is con-
strained by the promoter parameters according to
dðsnÞ , g1ðs0Þ b1
g
ðk0 þ k1Þ: ð3:7Þ
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Figure 4. Existence of the metabolic flux, product and first enzyme concentration. (a) The solution of steady-state equation (3.2) can be seen as the intersection of
two curves, h1(x) ¼ d(x)/g1(s0) and h2(x) ¼ b1(k0 þ k1s(x))/g. (b) The intersection does not exist when condition (3.9) fails.
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5— Effect of the RBS strengths. Using (3.1), we can write the
steady state of the downstream enzymes as
ei ¼ bib1
e1; for all i  2; ð3:8Þ
which indicates that a higher bi/b1 ratio leads to a higher
concentration for the ith enzyme. Taken together,
equations (3.3) and (3.8) indicate that the concentrations
of enzymes and intermediates can both be adjusted by
tuning the RBS ratio bi/b1. Comparing the dependencies
of (3.3) and (3.8) on the RBS ratio reveals a design trade-
off between enzyme expression and the intermediate
metabolite concentrations (figure 5a): low bi/b1 ratios
lead to low enzyme expression levels at the expense of
high concentrations for the intermediates. Conversely,
high bi/b1 ratios tend to increase enzyme expression
(and therefore the gene expression burden on the host
cell) in favour of low concentrations for the intermediates.
In the above discussion, we have implicitly assumed that a
solution to equations (3.2) and (3.3) exists. However, becauseof the saturable characteristic of the product consumption rate
(d) and enzymekinetics (gi), both equationsmay lack a solution.
Firstly, the solution of (3.2) can be computed as the intersection
of the two curves shown in figure 4. From these plots, we can
see that an intersection exists only when dmax/g1(s0 ). b1k
0/
g, or equivalently
b1 ,
dmaxg
g1ðs0Þk0 ; ð3:9Þ
which defines a constraint on the RBS strength of the first
enzyme. Since both sides of (3.2) are monotonic in sn, the
solution is unique. By equation (3.1), the existence of sn
also guarantees the existence of the steady-state enzyme
concentrations.
Secondly, since the enzyme turnover rates saturate at g^i,
equation (3.3) has a finite solution provided that
bi
b1
.
g1ðs0Þ
g^i
; for all i  2; ð3:10Þ
which defines a constraint on the bi/b1 ratio. Taken together,
conditions (3.9) and (3.10) define a feasible region in the RBS
rsif.royalsocietypublishing.org
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6strengths design space that prevents the accumulation of
intermediates and product (figure 5b). If the condition in
(3.9) is not satisfied, the substrate will be consumed at a
higher rate than the maximal product consumption, and
therefore the design will lead to an infinite accumulation of
the product. Likewise, violation of at least one of the
bounds in (3.10) will cause enzymatic saturation and lead
to infinite accumulation of an intermediate.
Conditions (3.9) and (3.10) link together genetic and
metabolic parameters (the RBS strengths bi and promoter
tightness k0, together with the substrate availability s0 and
the enzyme saturation g^i), and therefore they shed light on
how the design constraints appear due to the interplay
between metabolic and enzyme expression dynamics. In
figure 5c,d, we illustrate the effect of promoter tightness
and substrate availability on the feasible region for the RBS
strengths. Tighter promoters relax condition (3.9) and there-
fore enlarge the feasible region (figure 5c). In the limit case
of a perfect leak-less promoter (i.e. k0 ¼ 0), condition (3.9)
does not limit the RBS strength of the first enzyme. Conver-
sely, by conditions (3.9) and (3.10), a higher substrate tends
to tighten the feasible region (figure 5d ).
3.2. Adaptation to changes in cellular demand
One of the purposes of the genetic feedback circuit is to sus-
tain pathway operation under changes in the cellular demand
for product. From a control engineering standpoint, a change
in cellular demand can be seen as a perturbation signal acting
on the network. A useful approach to study dynamical sys-
tems under perturbations consists in examining their linear
approximation around their equilibrium points. If we write
the model (2.7) as _x ¼ FðxÞ and compute its Jacobian matrix
( J ¼ @F=@x), then trajectories starting in a small vicinity of
the steady state x can be approximated as
xðtÞ ¼ xþ
Xq
i¼1
Xqi
j¼1
aijt j1 elit; ð3:11Þ
where li, i ¼ 1, 2, . . . , q, are the q distinct eigenvalues of J
evaluated at x ¼ x, qi is the algebraic multiplicity of li and
the coefficients aij depend on the initial conditions and the
eigenvectors of the Jacobian. The terms t j1 eli t in (3.11),
known as feedback modes, provide a local approximation
of the trajectories around the equilibrium point.
In the case of the feedback system in (2.7), we can exploit
the structure of the Jacobian matrix to obtain analytic
expressions for its eigenvalues in terms of the design knobs
of the gene circuit (see appendix A.2 for details). We found
that the 2n eigenvalues can be classified into three categories
lfixed, lRBSi and lprom. The system has the following:
— (n2 1) stable eigenvalues at lfixed ¼ 2 g, 0. These eigen-
values are independent of the circuit design parameters,
and therefore they lead to fixed modes, which can be
adjusted only by changing the degradation rate (e.g.
with various degradation tags). They cannot be sup-
pressed or changed by tuning the circuit design knobs,
and, from (3.11), we see that they translate into (n 2 1)
modes of the form e2t/g, t e2t/g, . . . , tn22 e2t/g. The
enzyme degradation rates g are inversely proportional to
their half-lives, which are in turn much longer than meta-
bolic time scales (enzymatic half-lives are of the order of
minutes to hours, whereas metabolic time scales aretypically milliseconds to seconds [22]). Therefore, depend-
ing on the initial conditions the network can potentially
display very slow transients, and this appears to be aggra-
vated in long pathways.
— (n2 1) stable eigenvalues at
lRBSi ¼ ei g0iðsi1Þ , 0 for i ¼ 2; 3; . . . ;n; ð3:12Þ
with giðsi1Þ ¼ @gi=@si1jsi1 . 0. Since the steady-state
concentration of the enzyme ei; i  2, and the intermediate
si; i , n, depend only on the corresponding RBS ratio bi/b1
(see equations (3.3) and (3.8)), this ratio can be used to
independently fine-tune the feedback mode associated
with lRBSi.
— Two stable eigenvalues at
lprom ¼
ðgþ d0Þ+
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðd0  gÞ2 þ 4g1ðs0Þs0k1b1
q
2
; ð3:13Þ
with d0 ¼ d0ðsnÞ . 0 and s0 ¼ s0ðsnÞ , 0. Unlike lfixed and
lRBSi, these two eigenvalues depend on the steady-state
product concentration, and therefore they can be fine-
tuned through the promoter characteristic (see equation
(3.2)). To study the dependence of lprom on the promoter
design parameters, we computed them for a pathway with
realistic parameter values. In figure 6a, we show the
steady-state values of the product, flux and first enzyme
level for a wide span of promoter dynamic range m. We
observe that strong promoters tend to increase pathway
flux, in agreement with the sensitivity equation previously
derived in (3.5). We also see that, as shown by the steady-
state relation dðsnÞ ¼ g1ðs0Þe1, the flux corresponds to a
scaled version of the concentration of the first enzyme.
In figure 6b, we plot the location of the promoter-depen-
dent eigenvalues lprom in the complex plane. These
indicate that, in the case of weak promoters, the eigen-
values lprom lie on the real axis, becoming complex only
for a sufficiently broad dynamic range m. For strong pro-
moters, the real part <flpromg becomes closer to the
imaginary axis, potentially leading to slow transients.
Moreover, since stronger promoters lead to a higher flux,
the eigenvalues in figure 6b suggest that flux maximiza-
tion may entail a reduction in the response speed.
To illustrate the dynamic response of a pathway under the
control of the transcriptional control circuit, we simulated the
network under a change in the cell demand for product (see
figure 7a). We modelled a change in the cell demand as a
slow S-shaped temporal increase in the maximal product con-
sumption rate dmax (see the inset in figure 7a). This describes,
for example, cases in which the demand increase is due to
native processes upregulating the enzyme that metabolizes
the product. Note that, from the steady-state equation in
(3.2), a higher dmax inevitably leads to a higher flux and
a lower steady-state product concentration (see also
figure 4a). Before the perturbation, the network is in steady
state with a pre-stimulus flux dpre ¼ 19.5 mMmin21. We con-
sidered a Michaelis–Menten consumption rate of the form
d(sn) ¼ dmaxsn/(Kd þ sn), with Kd being the product concen-
tration needed for half-maximal consumption. Upon the
increase in dmax at t ¼ 50 min, we observe that the promoter
responds to the drop in product concentration and upregu-
lates enzyme expression so as to drive the pathway to a
new post-stimulus flux dpost that is approximately 40 per
cent higher than dpre, and a product concentration that is
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7approximately 20 per cent lower than its pre-stimulus value.
Using equations (3.1) and (3.2), we can compute the enzyme
upregulation factor as
eposti eprei
eprei
¼ k
0 þ k1sðspostn Þ
k0 þ k1sðspren Þ
 1 ¼ d
post  dpre
dpre
; ð3:14Þ
which is equivalent to the relative change in pathway flux.
The dynamic upregulation of enzyme expression can beseen in the lower panel of figure 7a, where we can also
verify that the upregulation factor is approximately 40 per
cent as predicted in (3.14). Note that as a consequence of
the operon architecture, all the enzymes are upregulated by
the same fold-factor. This factor depends on the pre- and
post-stimulus fluxes, which by (3.2) depend only on the
promoter design and first RBS strength.
As a way of comparison, in figure 7a, we have also simu-
lated the response of a pathway without feedback regulation
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8(i.e. with constant enzyme levels eiðtÞ ¼ e prei chosen to match
the flux of the controlled case dpre). The uncontrolled pathway
is unable to increase the flux, and we observe that this leads
to a considerable decrease in product concentration (approx.
70% reduction). In the uncontrolled case, the rate of substrate
uptake is fixed to v1
unc so that the equilibrium product satisfies
dðsuncn Þ ¼ vunc1 ; ð3:15Þ
and therefore any increase in dmax translates into a lower pro-
duct concentration suncn , which in turn depends only on the
kinetic parameters of the consumption rate d(sn). In contrast,
the feedback-controlled pathway can partly compensate the
drop in product by dynamically upregulating enzyme
expression, substantially outperforming the uncontrolled case.
We study the performance of the control circuit in more
detail in figure 7b, where we show the drop in product concen-
tration relative to the pre-stimulus level as a function of the
change in flux and dynamic range of the promoter. We observe
that stronger promoters can significantly improve the compen-
sation of the drop in product concentration (a perfect
compensation would correspond to a flat curve at 0% in
figure 7b). For example, under a 50 per cent increase in the path-
way flux, a mild promoter (m ¼ 10) leads to a drop in product of
approximately 47 per cent, whereas a strong promoter (m ¼ 100)
can bringdown the drop in product to approximately 20 per cent
(the latter corresponds to the design simulated in figure 7a). As
predicted by the upper bound in (3.7), the flux is limited by
the promoter strength, and therefore weak promoters do not
allow for large increases in flux (as a consequence, the domain
of the curves in figure 7a decreases with decreasing promoter
strength); for example, for the weakest promoter tested, the
flux could not be increased beyond approximately 10 per cent.4. Circuit design for compensation of flux
perturbations
A common strategy in metabolic engineering is to modify
bacteria by expressing heterologous enzymes that convertnatural metabolic intermediates into a compound of interest
[19]. The target compound is synthesized by ‘branching
out’ a specific intermediate from a natural pathway, and
therefore part of the metabolic flux needed to sustain the
host native processes is redirected to the production of the
foreign chemical. The choice of a good branching point (i.e.
one that does not lead to lethal metabolic imbalances for
the host) is a major problem typically addressed with the
aid of optimization-based computational tools [31,32]. In
this section, we turn our attention to the effect of a pertur-
bation in the native flux as a consequence of branching out
from an intermediate metabolite.
4.1. Trade-offs and constraints in the design of the RBS
strengths
To account for an engineered pathway consuming the inter-
mediate s‘ at a constant rate dext, we include dext as a
consumption rate in the ODE for s‘
_si ¼ giðsi1Þei  giþ1ðsiÞeiþ1; i  f‘; ng;
_s‘ ¼ g‘ðs‘1Þe‘  g‘þ1ðs‘Þe‘þ1  dext;
_sn ¼ gnðsn1Þen  dðsnÞ;
_ei ¼ biðk0 þ k1sðsnÞÞ  gei; i ¼ 1; 2; . . . ;n:
9>>=
>>;
ð4:1Þ
The system is shown in figure 8a, and in this case the
steady-state equation for the product and the first enzyme is
dðsnÞ þ dext
g1ðs0Þ ¼
b1
g
ðk0 þ k1sðsnÞÞ; ð4:2Þ
where the left-hand side is a shifted version of the one in (3.2).
For the intermediates before the branch point, the steady-state
concentration is given by the same equation as in (3.3)
giðsi1Þ ¼ g1ðs0Þ b1bi ; 2  i  ‘; ð4:3Þ
whereas for the intermediates after the branch point, we have a
modified equation
giðsi1Þ ¼ g1ðs0Þ b1bi 
dext
ei
; i . ‘; ð4:4Þ
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9with ei ¼ ðbi=gÞðk0 þ k1sðsnÞÞ. From these steady-state
equations, we observe similar properties as in the case without
a branch. The promoter characteristic and the first RBS strength
determine the metabolic flux, whereas the RBS ratio bi/b1 can
be used to fine-tune the balance between enzyme expression
and the concentrations of the intermediates. In addition, in this
case, we see that the intermediates after the branch point also
depend on the promoter characteristic.
Using similar arguments to those in figure 4, we find that
a solution to (4.2) exists if
b1 ,
ðdmax þ dextÞg
g1ðs0Þk0 ð4:5Þ
and
b1 .
dextg
g1ðs0Þðk0 þ k1Þ : ð4:6Þ
For equation (4.4) to have a solution, in principle, we need
ðg1ðs0Þb1=bi  dext=eiÞ , g^i, but this condition is less stringent
than the one previously derived in (3.10) for the case dext ¼ 0.
Since the design must also prevent the accumulation of
intermediates in the absence of perturbations, we conclude
that (3.10), i.e.
bi
b1
.
g1ðs0Þ
g^i
; for all i  2; ð4:7Þ
is sufficient for the existence of all the intermediates. The
inequalities in (4.5)–(4.7) define the feasible region for the
RBS design space under a perturbation consuming one of
the intermediates (see figure 8b). As in the case without the
branch (figure 5b), the limits (4.5) and (4.7) prevent theaccumulation of the product and intermediates, respectively.
The condition in (4.6), however, adds a new type of constraint
to the design space: it guarantees that the synthetic gene cir-
cuit can upregulate enzyme expression strongly enough to
cope with the flux through the branch, hence preventing
the depletion of the product. This new constraint also
depends on the promoter dynamic range, which was absent
in the case without a branch. From (4.5) and (4.6), we can
compute the gap between the upper and lower bounds for
the first RBS strength (see figure 8b)
D ¼ g
g1ðs0Þk0 dmax þ dext
m 1
m
  
; ð4:8Þ
which reveals that promoters with a broad dynamic range
and small leakage enlarge the RBS design space (see
figure 8c).4.2. Adaptation to a flux perturbation
To illustrate the effect of an engineered branch on the
dynamic response of the feedback system, we simulated a
network with two metabolites and two enzymes under a
flux perturbation that consumes the intermediate s1 (see
figure 9a). Before the perturbation, the network is in steady
state with a native flux dpre ¼ 19.5 mMmin21. We modelled
the engineered branch as an S-shaped increasing rate dext(t)
(see the inset in figure 9a). Upon the activation of the
branch, induced at t ¼ 50min, the synthetic operon circuit
upregulates enzyme expression by approximately 45 per
cent to drive the pathway to a new native flux dpost. Using
equation (3.1), together with the pre- and post-stimulus
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10steady-state equations ((3.2) and (4.2)), we find that the
enzymes are upregulated by the factor
eposti eprei
eprei
¼ k
0 þ k1sðspostn Þ
k0 þ k1sðspren Þ
 1
¼ d
post þ dext
dpre
 1
¼ d
post  dpre
dpre|ﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄ}
change in
native flux
þ dext
dpre
:|ﬄ{zﬄ}
effect of
branch
ð4:9Þ
As in the case without the branch, the expression in (4.9)
indicates that all enzymes are upregulated by an identical
fold-factor that depends on the promoter design and the
first RBS strength.
In figure 9a, we have also simulated the response of a
pathway without feedback regulation (i.e. with constant
enzyme levels etðtÞ ¼ eprei chosen to match the flux dpre of
the controlled case). In terms of both flux and product con-
centration, we observe that the feedback-controlled network
displays a dramatic improvement compared with the uncon-
trolled case: the operon circuit reduces the loss in native flux
from 50 per cent to approximately 5 per cent, whereas the
decrease in steady-state product concentration is brought
down from approximately 82 per cent to 20 per cent. In the
uncontrolled case, the rate of substrate uptake is fixed to
v1
unc and therefore the post-stimulus flux is given by
dpostunc ¼ vunc1  dext; ð4:10Þ
and hence the post-stimulus flux scales linearly with the rate of
the branch. In figure 9b,we show this linear dependence together
with the feedback-regulated case for awide span of the promoter
dynamic range.We observe that the feedback control circuit out-
performs the uncontrolled case even with promoters with a
narrow dynamic range, and that this improvement can be
achieved with a relatively low enzyme upregulation factor.5. Discussion and outlook
In this paperwe have presented a detailed analysis of a synthetic
gene circuit designed to dynamically control metabolic path-
ways. The goal of this feedback control system is twofold: to
adjust pathway activity so as to match the cell demand for pro-
duct, and to dampen flux perturbations that divert the native
flux to the synthesis of foreign molecules. The control strategy
relies on encoding the metabolic genes in a single operon
repressed by a product-responsive TF. The TF can sense a drop
in product concentration and upregulate enzyme expression to
bring the pathway close to its homeostatic levels.
Since the seminal operonpaper [33], the interaction between
the genetic machinery and metabolism has been extensively
studied in the context of natural systems. These studies typically
focus on understanding how observed phenotypes emerge
from the genetic–metabolic cross talk [34–38], and a number
of detailed mechanistic models for operon regulation have
been developed (e.g. [20,21]). The goal in synthetic biology,
however, is to design regulatory circuits for controlling metab-
olism in a customized fashion. Model-based design therefore
requires mathematical descriptions that are explicitly parame-
terized in terms of the design knobs that can be manipulated
in synthetic biology applications. Consequently, we have useda gene expression model that is deliberately not mechanistic,
and instead describes the genetic feedback in terms of tuneable
parameters such as the promoter’s dynamic range, RBS
strengths and protein half-lives. This approach has proved to
be adequate to explore the genetic design space and to quantify
the impact of the promoter characteristic and RBS strengths on
the system response.
A typical complication in engineered pathways is that enzy-
matic saturation may cause intermediates to accumulate in
prohibitively large concentrations, thus affecting the viability
of the host due to toxic effects [11]. Metabolite accumulation
arises when the steady state lies beyond the saturation limit of
a catalytic step, and available models for pathways under tran-
scriptional regulation [20,39–41] have generally overlooked the
impact of enzyme saturation on the existence of a metabolic
steady state. In our aim to carry out a general analysis, we
have used a metabolic model that accounts for a whole class
of saturable enzyme kinetics under mild assumptions. By expli-
citly accounting for enzyme saturation, we characterized a
feasible set for the design parameters which ensures that the
steady state lies within the saturation limits. The feasible
set also guarantees the local stability of the network, and we
found that the constraints on the RBS strengths can be relaxed
with the use of promoters with a high dynamic range and
small leakiness. The geometry of the feasible set depends on a
combination of genetic and kinetic parameters, thus highlight-
ing the emergence of design constraints as a consequence of
the interplay between the genetic and metabolic subsystems.
The steady-state equations reveal a trade-off between the
steady-state enzyme expression levels and the concentration
of intermediates: the enzyme concentrations are inversely
proportional to the concentration of the intermediate they cat-
alyse. We found that a critical parameter is the RBS ratio,
i.e. the relative strength of an RBS with respect to the strength
of the first one in the operon, which can be used to fine-
tune the circuit between high-enzyme/low-intermediate or
low-enzyme/high-intermediate designs.
The two considered design knobs, promoter characteristic
and RBS strengths, seem to have decoupled roles in the
steadystate and transient behaviourof the network. Thepromo-
ter characteristic together with the first RBS determine the
steady state of the product and the first enzyme. A strong pro-
moter and a strong RBS for the first enzyme can be used to
increase the pathway flux, but this may come at the expense
of slow modes in the transient response. In the absence of an
engineered pathway consuming an intermediate, the remaining
RBS strengths can be used to independently adjust the concen-
trations of the intermediates and the remaining enzymes. In the
case of consumption of an intermediate, however, this design
rule applies only to the metabolites upstream of the consumed
intermediate, i.e. the steadystate of the downstreammetabolites
depends on a combination of the RBS strength, promoter
characteristic and the size of the perturbation.
The closed-form expressions for the transient modes of
the feedback system show further evidence of the separation
principle between promoter and RBS design. From the 2n
modes of an n-step pathway, we found that only two
depend on the promoter characteristic, whereas further
(n 2 1) modes depend exclusively on the RBS ratio. The
remaining (n 2 1) modes correspond to the enzyme half-
lives and are independent of the promoter characteristic
and RBS strengths. Since enzyme half-lives are considerably
slower than metabolic time constants (even with the use of
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11protein degradation tags), the system dynamics can be
dominated by slow transients.
We ran numerical simulations that demonstrate the poten-
tial of the proposed control strategy. Using physiologically
realistic parameter values for E. coli, the synthetic operon control
circuit can dramatically compensate the loss in flux by sensing
the drop in product concentration and subsequently upregulat-
ing the enzyme concentrations. The feedback-controlled
pathway outperforms the uncontrolled one even when weak
promoters are used, thus underscoring the tremendous
advantage of taking a feedback approach to metabolic control.
In this work we focused on a control circuit with an operon
architecture, a choice inspired by the fact that operons
are oneof thebuildingblocks ingenome-widebacterial networks
[42]. The ubiquity of natural metabolic pathways under operon
regulation [43]makes thema reasonable choice as template archi-
tectures for engineered circuits. In addition, themain difficulty in
building genetic–metabolic systems is to find suitable regulatory
molecules to interface a metabolite of interest with the genetic
machinery. Someof the available alternatives are engineeredpro-
moters [44,45], metabolite-responsive riboswitches [18,46,47]
and natural TFs (for a comprehensive catalogue of natural
metabolite-responsive TFs see Zhang et al. [14, supp. table 5]).
In this respect, an operon architecture stands as a simpleyet effec-
tive topology, as it requires only one metabolite-responsive TF.
More complex architectures can certainly add more flexibility
to the design, but this will probably come at the expense of
more intricate relationships between the design parameters and
the metabolic response. For example, the use of multi-promoter
circuits allows for independent tuning of the enzyme upregula-
tion factor, but at the same time the pathway may display
sustained oscillations if the characteristics of the different
promoters are not carefully designed [26].
We should point out that the derived design constraints
guarantee the existence and stability of the metabolic steady
state, and thus they are only baselines for the correct function-
ing of the genetic control circuit. In most applications, the
design must also account for more demanding objectives
such as maximization of flux, minimization of energy expen-
diture, or a combination of these. Since these objectives may
conflict with each other, selecting an appropriate combi-
nation of circuit parameters requires the use of multi-
objective optimization methods within the feasibility sets
derived here (see, for example, figures 5 and 8). Optimization
routines can therefore be used to single out the parameter
values that lead to an acceptable compromise between
mutually colliding objectives; see Banga [48] for a review of
a number optimization methods available.
Asaconsequenceof acompromise betweenmodel complex-
ityand the generalityof the analytic results, our results have two
main limitations. Firstly, we have restricted the analysis to path-
ways with irreversible reactions, and, secondly, our results are
limited to unbranched pathways operating in isolation of the
remaining metabolism of the host cell. Enzymatic reactions are
inherently reversible processes and, although many biosyn-
thetic reactions operate in a regime where the forward reaction
is much more likely to occur than its backward counterpart
[22], their reversibility cannot always be neglected [49]. In our
case, the use of irreversible reactions is an important simplifica-
tion that allowed thederivation of intuitive and easy to interpret
relations between the network parameters and its steady state.
Other instances where the analysis of irreversible pathways
led to new insights into biological design principles include,for example, the works in [38,43]. Our derivation of the design
constraints on the promoter parameters and RBS strengths
relies on the structure of the steady-state equations and the
fact thatmost of them are decoupled from each other. However,
in the case of an n-step pathway with reversible reactions, the
steady-state equations form a system of 2n coupled algebraic
equations. These equations may admit an analytic solution for
specific enzyme kinetics (see Heinrich & Klipp [50] for the sol-
ution in the case of linear and Michaelis–Menten kinetics with
constant enzyme concentrations), but its extension to transcrip-
tionally controlled enzymes and general reversible kinetics is
cumbersome and lies outside the scope of our paper.
A possible workaround to deal with reversible kinetics is to
exploit the natural timescale separation between enzyme
expression and metabolic reactions. In this approach, the metab-
olite trajectories are assumed to evolve in amuch faster time scale
than the enzyme concentrations. This allows us to approximate
the metabolite concentrations as algebraic functions of the
enzymes, leading to an enzyme-only ODE model subject to
the algebraic relations between metabolites and enzymes. We
have previously used such an approach in the case of ON–OFF
promoters [36] (i.e. promoters that are either fully active or inac-
tive, without intermediate levels of gene expression), and future
work will focus on its use with graded promoters such as those
considered here. Another advantage of the time scale separation
is that it may allow for the analysis of pathways with more com-
plex stoichiometries. This is of enormous relevance in practical
applications, as the cross talk between the controlled pathway
and the rest of the hostmetabolism is likely to have a detrimental
impact on the performance of the feedback control system.
We are exploring a number of extensions to this work,
aiming primarily at the use of alternative feedback topologies
and at quantifying the impact of biochemical noise on the path-
way performance. The implementation of genetic–metabolic
circuits, let alone parameter fine-tuning, can be costly and
time-consuming. Our work provides a first step towards under-
standing the fundamental limitations and trade-offs that must
be addressed at the design stage, potentially facilitating the
implementation using a model-guided rationale.
We thank Dr John Heap for fruitful discussions and all the members of
the Control Engineering for Synthetic Biology group at Imperial College
London. We also thank the anonymous referees, whose detailed and
constructive feedback considerably improved this paper.Appendix A
A.1. Derivation of the sensitivities
To obtain the sensitivities in (3.4)–(3.6), we differentiate the
steady-state equation in (3.2) with respect to the parameter
of interest, and then use the chain rule. For example, to
obtain (3.4) we differentiate (3.2) with respect to k0
d0ðsnÞ
g1ðs0Þ
dsn
dk0
¼ b1
g
þ b1k
1
g
s0ðsnÞ d
sn
dk0
; ðA1Þ
and then solve for dsn =dk0 to obtain
dsn
dk0
¼ b1
g
FðsnÞ; ðA2Þ
where FðsnÞ ¼ ðd0ðsnÞ=g1ðs0Þ  ðb1k1=gÞs0ðsnÞÞ1. The remain-
ing sensitivities dsn =dk1 and dsn =db1 can be calculated in an
analogous manner.
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12A.2. Local stability analysis
Here we show that, under the conditions (3.9) and (3.10), the
network (2.7) has a locally stable steady state. Moreover, its
Jacobian has:
— n2 1 stable eigenvalues at lfixed ¼ 2 g;
— n2 1 stable eigenvalues at lRBSi ¼ g0i ei, i ¼ 2; 3; . . . ;n; and
— and two stable eigenvalues at
lprom ¼
ðgþ d0Þ+
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðd0  gÞ2 þ 4g1ðs0Þs0k1b1
q
2
: ðA3Þ
We first write the vector of metabolite and enzyme con-
centrations as s and e, respectively, so that the model (2.7)
can be written as
d
dt
s
e
 
¼ f
sðs; eÞ
f eðsn; eÞ
 
: ðA4Þ
The conditions in (3.9) and (3.10) guarantee the existence of
the steady state. The entries of the Jacobian matrix are
@f si
@sj
¼
ai; j ¼ i 1;
aiþ1; j ¼ i;
0 otherwise;
8<
: ðA5Þ
@f si
@sj
¼ k
1
i s
0ðsnÞ; j ¼ n;
0 otherwise;

ðA6Þ
@f si
@ej
¼
giðsi1Þ; j ¼ i;
giþ1ðsi1Þ; j ¼ iþ 1;
0 otherwise;
8<
: ðA7Þ
and
@f ei
@ej
¼ g for all j; ðA8Þ
and the coefficients ai are defined as
ai ¼ g0i ei; i ¼ 2; 3; . . . ;n ðA9Þ
and
anþ1 ¼ d0ðsnÞ: ðA10Þ
Note that because gi and d are non-decreasing, it follows that
ai  0. Using (3.3), we can write the terms giðsi1Þ in terms
of the RBS ratio
giðsi1Þ ¼ g1ðs0Þ bib1
 1
: ðA11Þ
We can therefore write the Jacobian as a block matrix
J ¼ J11 J12
J21 J22
 
; ðA12Þ
where the four blocks are n n matrices
J11 ¼
a2 0 0    0
a2 a3 0    0
0 a3 . .
. . .
. ..
.
..
. . .
. . .
. an ..
.
0       an d0
2
6666664
3
7777775
; ðA13ÞJ12 ¼ g1ðs0Þb1
b11 b12 0    0
0 b12 b13    0
0 0 b13
. .
. ..
.
..
. . .
. . .
. . .
. b1n
0          b1n
2
666666664
3
777777775
ðA14Þ
and J21 ¼ k1s0
0    0 b1
..
. . .
. . .
.
b2
..
. . .
. . .
. ..
.
0    0 bn
2
66664
3
77775; J22 ¼ gI: ðA15Þ
The characteristic polynomial of J (i.e. p(l)¼ det( J 2 lI)) is
pðlÞ ¼ detðJ22  lIÞdetððJ11  lIÞ  J12ðJ22  lIÞ1J21Þ
¼ ð1Þnðlþ gÞndet J11  lIð Þ þ J12J21
lþ g
 
ðA16Þ
where the product J12J21 is
J12J21 ¼ q
0 0    0
0 0    0
..
. . .
. . .
. ..
.
0 0    1
2
6664
3
7775 ðA17Þ
and q ¼ g1(s0 )s0k1b1. From the structure of J11 and theproduct J12-
J21, we can carry one (l þ g) term into the determinant in (A 16)
and then into the last column of its argument. This leads to
pðlÞ ¼ ðlþ gÞn1pðlÞ: ðA18Þ
The factor pðlÞ is a polynomial given by
pðlÞ ¼ det
ðlþ a2Þ 0    0
a2 . .
.    ...
..
. . .
. ðlþ anÞ 0
0    an ðlþ d0Þðlþ gÞ  q
2
666664
3
777775
0
BBBBB@
1
CCCCCA
¼
Yn
i¼2
ðlþ aiÞððlþ d0Þðlþ gÞ  qÞ: ðA19Þ
We therefore conclude that the Jacobian J has (n2 1)
stable eigenvalues at l¼2 g, 0, (n2 1) stable eigenvalues at
l¼2 ai, 0, for i¼ 2, 3, . . ., n, and two eigenvalues at
l1;2 ¼

 ðgþ d0Þ+
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðd0  gÞ2 þ 4g1ðs0Þs0k1b1
q 
2
: ðA20Þ
These last two eigenvalues are also stable because d0 . 0 and
s0 , 0 imply that the quadratic polynomial
ðlþ d0Þðlþ gÞ  g1ðs0Þs0k1b1 ðA21Þ
has only positive coefficients and therefore its roots satisfy
<fl1;2g, 0.
rsif.r
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